News & Updates

Back to All News
Get Care

Lankenau Medical Center emergency medicine physician, Basil Harris, MD, wins Tricorder XPrize Competition

Lankenau Medical Center April 18, 2017 News Releases

Dr. Harris’ seven-member team beat 312 teams from 38 countries

Basil Harris, MD, an emergency medicine specialist at Lankenau Medical Center and affiliate clinical member of the Lankenau Institute for Medical Research, both part of Main Line Health, and his team, Final Frontier Medical Devices, took home the top prize of $2.5 million in Qualcomm’s XPRIZE competition.

The competition challenge, launched in 2012, was to invent a Star Trek-inspired tricorder with the capability of diagnosing 13 conditions and monitoring vital signs. Dr. Harris’s entry, named DxtER, can diagnose 34 conditions and transmit information to medical providers—from home. DxtER includes a collection of non-invasive sensors designed to collect data about vital signs, body chemistry and biological function.

“This truly is a new revolution in health care and we are just seeing the beginning,” says Dr. Harris. “This competition was a wonderful demonstration of technology and my team and I were honored to be among such talented peers across the globe. The hard work really begins now—right here at Lankenau Medical Center and Main Line Health—where we are starting clinical trials of the device and working on gaining the appropriate FDA approvals.”

The seven-member, self-funded Final Frontier Medical Devices team beat 312 teams from 38 countries, including the second place team backed by the Taiwan government and cellphone company HTC and led by a Harvard researcher. Dr. Harris’s team included his four siblings. His wife and children also helped bring the device to life—designing and testing prototypes, editing documents, and overseeing the wiring and sanding of the devices made on 3D printers.

Learn more about Dr. Harris’ work in the Qualcomm’s XPRIZE competition in Main Line Health’s Physician magazine.

About Main Line Health

Founded in 1985,Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health’s commitment—to deliver advanced medicine to treat and cure disease while also playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.

At Main Line Health’s core are four of the region’s most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.

Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare,one of the region’s largest multispecialty physician networks.

Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation’s highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association’s #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.

About Lankenau Medical Center

Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau Medical Center has been named among the top 10 hospitals in Pennsylvania and top five in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals 2019–20, and was ranked as high-performing in abdominal aortic aneurysm repair, aortic valve surgery, colon cancer surgery, gastroenterology & GI surgery, geriatrics, heart bypass surgery, heart failure, hip replacement, knee replacement, lung cancer surgery and nephrology. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.

About Lankenau Institute for Medical Research

Lankenau Institute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians.